81 新抗生物質Glysperin (Bu-2349)の構造
スポンサーリンク
概要
- 論文の詳細を見る
Glysperin (Bu-2349) is a complex of basic, water-soluble antibiotics produced by a strain of Bacillus cereus. The antibiotic complex comprises three components, A (1a), B (1b) and C (1c). They showed potent antibacterial activity against gram-positive and gram-negative organisms, 1a being the major and most active component. The structures of 1a, 1b and 1c were determined on the basis of chemical degradation studies in conjugation with spectroscopic analyses. 1a (C_<44>H_<75>N_7O_<18>) was shown by acid hydrolysis to contain L-alanine, p-hydroxybenzoic acid, a C_<11>-alkyl tetramine and four sugar moieties. The structure of the C_<11>-amine was determined to be 1,13-diamino-4,9-diazatridecane (8), a new compound, whose structure was confirmed by synthesis. Three of the four sugar moieties were identified as D-ribose, D-galactose and 2,4-diamino-2,4,6-trideoxy-D-galactose. The fourth sugar moiety was a novel exoenohexose and its structure was established as 6-deoxy-D-xylo-hex-5-enose (9) based on the degradation studies performed after catalytic hydrogenation of 1a. The sequence of these structural units in 1a was elucidated by the spectroscopic studies on its partial degradation products. 1b (C_<40>H_<66>N_6O_<18>) was found to possess spermidine in place of 8 in 1a, while 1c (C_<44>H_<77>N_7O_<19>) contained D-glucose instead of 9 in 1a. Glysperins A, B and C are, in some respects, structurally related to the glycocinnamoylspermidine antibiotic LL-BM 123 which was produced by a strain of Nocardia species.
- 天然有機化合物討論会の論文
- 1980-09-10
著者
-
小西 正隆
ブリストル・マイヤーズ研
-
小西 正隆
ブリストルマイヤーズスクイブ東京研究所
-
小西 正隆
Bristol-myers Squibb Research Institute
-
都野 孝
Bristol-Myers Squibb Research Institute
-
都野 孝
ブリストル万有研究所
関連論文
- 抗腫瘍性抗生物質、BMY-28438に関する研究(有機化学・天然物化学-抗生物質-)
- 47 Dynemicin A及び関連化合物の生合成と活性(口頭発表の部)
- Complete Structures of Breynins A and B
- 82 4個のテトロン酸部を有する大環状抗生物質Quartromicin A_1,A_2,A_3の構造と化学的性質(口頭発表の部)
- 72 新セスタテルペン抗生物質terpestacin (BU-4641V)に関する研究(ポスター発表の部)
- 新規抗ウィルス抗生物質複合体、BMY-28190に関する研究(有機化学・天然物化学-抗生物質-)(受賞講演)
- 340 最近の抗腫瘍抗生物質
- ビシクロジイネン抗生物質の化学, 生活活性, 作用機構
- 新しい抗腫瘍性抗生物質--Esperamicinグル-プを中心として
- 81 新抗生物質Glysperin (Bu-2349)の構造
- ラジカルを発生する制がん抗生物質
- ジイネン抗生物質の化学構造と合成研究--その構造単位の生物活性における役割を中心として (「癌化学療法の展望」特集号)
- ジイネン抗生物質の化学構造と合成研究 : その構造単位の生物活性における役割を中心として